Pharmaceutical

Sentynl acquires Eiger’s Zokinvy for progeria treatment

Sentynl Therapeutics has announced the acquisition of Zokinvy programme from Eiger BioPharmaceuticals for the treatment of progeria.

May 7, 2024 - 00:00
Sentynl acquires Eiger’s Zokinvy for progeria treatment
Sentynl Therapeutics has announced the acquisition of Zokinvy programme from Eiger BioPharmaceuticals for the treatment of progeria.
Read the original article

Tags:

Previous Article

UK MHRA approves ViiV Healthcare’s cabotegravir formulations for HIV-1

Next Article

Amgen reports a 22% increase in Q1 2024 net revenues

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech

Vivek Ramaswamy’s brashness made waves in the Republica...

Aug 25, 2023

Viatris gets grant for nasal spray method for treating ...

Apr 25, 2024

Why doesn’t the U.S. have more Black midwives?

Why doesn’t the U.S. have more Black midwives?

Sep 18, 2023